prof. dr. Philippe Gevaert
- ORCID iD
-
0000-0002-1629-8468
Show
Sort by
-
- Journal Article
- A1
- open access
Comorbid chronic rhinosinusitis and asthma : shared risk factors and treatment implications : an EAACI Task Force Report
-
- Journal Article
- A1
- open access
Allergy to cats : current perspectives and therapeutic options
-
Chitin is a potent inducer of type 2 airway inflammation independent of endogenous chitinolytic activity
-
- Journal Article
- A1
- open access
Mechanisms and kinetics of wound healing in chronic rhinosinusitis patients after complete sinus surgery and its improvement by doxycycline therapy
-
Nasal mucosal brushings could be used to define the endotype in nasal inflammatory diseases
(2025) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 155(2, Supplement). p.AB77-AB77 -
Real-life effectiveness of mepolizumab and omalizumab in sever uncontrolled chronic rhinosinusitis with nasal polyps : a prospective study
(2025) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 155(2, Supplement S). p.AB456-AB456 -
A study of dupilumab in adults with CRSsNP : results from the Liberty ORION study
(2025) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 155(2, Supplement S). p.AB76-AB76 -
Nouveau dispositif pour les tests cutanés : validation du seuil du Skin Prick Automated Test (SPAT) chez des patients allergiques au pollen de bouleau et aux acariens
-
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST) : a multicentre, randomised, double-blind, head-to-head phase 4 trial
-
- Journal Article
- A2
- open access
EUFOREA meeting on defining disease states in allergic rhinitis : towards a unified language in AR